Vasoactive intestinal polypeptide: Measurement, distribution and putative neurotransmitter function

Digestion

Volumn 19, Issue 3, 1979, Pages 149-169

  Fahrenkrug, Jan ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Neurotransmitter; Radioimmunoassay; Vasoactive intestinal polypeptide (VEP); VIPergic neurons

Indexed keywords

ACETYLCHOLINE; ADENINE NUCLEOTIDE DERIVATIVE; CHOLECYSTOKININ; ENKEPHALIN; GASTRIN; GLUCAGON; HISTAMINE; HORMONE; NEUROTENSIN; NEUROTRANSMITTER; PROSTAGLANDIN DERIVATIVE; PROTIRELIN; SECRETIN; SEROTONIN; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE I 125;

CENTRAL NERVOUS SYSTEM; DIGESTIVE SYSTEM; DRUG MECHANISM; ETIOLOGY; GASTROINTESTINAL TRACT; NERVOUS SYSTEM; PANCREAS; RADIOIMMUNOASSAY; REVIEW;

ADRENAL GLANDS; AMINO ACID SEQUENCE; ANIMAL; BICARBONATES; BIOLOGICAL ASSAY; CENTRAL NERVOUS SYSTEM; CEREBRAL ARTERIES; CHEMISTRY; DIGESTIVE SYSTEM; DOGS; GASTROINTESTINAL HORMONES; GUINEA PIGS; INTESTINE, SMALL; MUSCLE RELAXATION; NEURONS; NEUROTRANSMITTERS; RADIOIMMUNOASSAY; RATS; SECRETORY RATE; SWINE; SYNAPSES; UROGENITAL SYSTEM; VASOACTIVE INTESTINAL PEPTIDE; VASODILATION;

EID: 0018363461     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000198339     Document Type: Review

References (117)

1. Abrahamsson, H.: Studies on the inhibitory nervous control of gastric motility. Acta physiol, scand., suppl. 390, pp. 1-38 (1973).
2. Ahlman, H. and Enerback, L.: A cytofluorometric study of the myenteric plexus in the guinea pig. Cell Tiss. Res. 153: 419-434 (1974).
3. Ahlman, H., Enerback, L., Kewenter, J., and Storm, B.: Effects of extrinsic denervation on the fluorescence of monoamines in the small intestine of the cat. Acta physiol, scand. 89: 429-435 (1973).
4. Aim, P., Alumets, J., Hakanson, R., and Sundler, F.: Peptidergic (vasoactive intestinal peptide) nerves in the genito-urinary tract. Neuroscience 2: 751-754 (1977).
5. Arimura, A., Sato, H., Dupont, A., Nishi, N., and Schally, A.V.: Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science, N.Y. 189: 1007-1009 (1975).
6. Barbezat, G.O. and Grossman, M.I.: Intestinal secretion: stimulation by peptides. Science, N.Y. 174: 422-424 (1971).
7. Bataille, D., Freychet, P., and Rosselin, G.: Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Endocrinology 95: 713-721 (1974).
8. Biber, B.: Vasodilator mechanisms in the small intestine. Acta physiol, scand., suppl. 401, pp. 1-31 (1973).
9. Blaustein, M.P., Johnson, E.M., and Needleman, P.: Calcium-dependent norepinephrine release from presynaptic nerve endings in vitro. Proc. natn. Acad. Sci. USA 69: 2237-2240 (1972).
10. Bloom, S.R. and Polak, J.M.: VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome. Clin. Endocr. 5: suppl., pp. 223-228 (1976).
11. Bodanszky, M., Klausncr, Y.S., Lin, C.Y., Mutt, V., and Said, S.I.: Synthesis of the vasoactive intestinal peptide (VIP). J. Am. chem. Soc. 96: 4973-4978 (1974).
12. Bodanszky, M., Klausner, Y.S., and Said, S.I.: Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide. Proc. natn. Acad. Sci. USA 70: 382-384 (1973).
13. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R.: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, N.Y. 179: 77-79 (1973).
14. Bryant, M.G., Bloom, S.R., Polak, J.M., Albuquerque, R.H., Modlin, I., and Pearse, A.G.E.: Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet i: 991-993 (1976).
15. Buffa, R., Capella, C., Solcia, E., Frigerio, B., and Said, S.I.: Vasoactive intestinal peptide (VIP) cells in the pancreas and gastro-intestinal mucosa. Histochemistry 50: 217-227 (1977).
16. Burnstock, G.: Purinergjc nerves. Pharmac. Rev. 24: 509-581 (1972).
17. Burnstock, G., Campbell, G., Satchell, D., and Smythe, A.: Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol. 40: 668-688 (1970).
18. Cannon, W.B. and Lieb, C.W.: The receptive relaxation of the stomach. Am. J. Physiol. 29: 267-273 (1911).
19. Carraway, R. and Leeman, S.E.: Characterization of radioimmunoassayable neurotensin in the rat. J. biol. Chem. 251: 7045-7052 (1976).
20. Chang, M.M. and Leeman, S.E.: Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J. biol. Chem. 245: 4784-4790 (1970).
21. Christophe, J.P., Conlon, T.P., and Gardner, J.D.: Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Binding of radioiodinated peptide. J. biol. Chem. 251: 4629-4634 (1976).
22. Desbuquois, B.: The interaction of vasoactive intestinal polypeptide and secretin with liver-cell membranes. Eur. J. Biochem. 46: 439-450 (1974).
23. Desbuquois, B., Laudat, M.H., and Laudat, P.: Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes. Biochem. biophys. Res. Commun. 53: 1187-119 (1973).
24. Dockray, G.J.: Vasoactive intestinal peptide: secretin-like action on the avian pancreas. Experientia 29: 1510-1511 (1973).
25. Dockray, G.J.: Immunochemical evidence of cholecystokinin-like peptides in brain. Nature, Lond. 264: 568-570 (1976).
26. Domschke, S., Domschke, W., Rosch, W., Konturek, S.J., Spriigel, W., Mitznegg, P., Wunsch, E., and Demling, L.: Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man. Gastroenterology 73: 478-480 (1977).
27. Douglas, W.W.: Stimulus-secret ion coupling: the concept and clues from chromaffin and other cells. Br. J. Pharmacol. 34: 451-474 (1968).
28. Douglas, W.W. and Poisner, A.M.: Stimulus-secretion coupling in a neurosecretory organ: the role of calcium in the release of vasopressin from the neurohypophysis. J. Physiol., Lond. 172: 1-18 (1964).
29. Ebeid, A.M., Murray, P., Hirsch, H., Wesdorp, R.I.C., and Fischer, J.E.: Radioimmunoassay of vasoactive intestinal peptide. J. surg. Res. 20: 355-360 (1976).
30. Ebeid, A.M., Murray, P., Soetcrs, P.B., and Fischer, J.E.: Release of VIP by calcium stimulation. Am. J. Surg. 133: 140-144 (1977).
31. Ebeid, A.M., Soeters, P.B., Murray, P., and Fischer, J.E.: Release of vasoactive intestinal peptide (VIP) by intraluminal osmotic stimuli. J. surg. Res. 23: 25-30 (1977).
32. Emson, P.C., Fahrenkrug, J., Schaffalitzky de Muckadell, O.B., Jessell, T.M., and Iversen, L.L.: Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Res. 143: 174-178 (1978).
33. Fahrenkrug, J., Galbo, H., Holst, J.J., and Schaffalitzky de Muckadell, O.B.: Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract. J. Physiol., Lond. 280: 405-422 (1978).
34. Fahrenkrug, J., Haglund, U., Jodal, M., Lundgren, O., Olbe, L., and Schaffalitzky de Muckadcll, O.B.: Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications. J. Physiol., Lond. 284: 291-305 (1978).
35. Fahrenkrug, J. and Schaffalitzky de Muckadell, O.B.: Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J. Lab. clin. Med. 89: 1379-1388 (1977).
36. Fahrenkrug, J. and Schaffalitzky de Muckadell, O. B.: Distribution of vasoactive intestinal polypeptide (VIP) in the porcine central nervous system. J. Neurochem. 31: 1445-1451 (1978).
37. Fahrenkrug, J., Schaffalitzky de Muckadell, O.B., and Fahrenkrug, A.: Vasoactive intestinal polypeptide (VIP) in human cerebrospinal fluid. Brain Res. 124: 581-584 (1977).
38. Fahrenkrug, J., Schaffalitzky de Muckadell, O.B., Holst, J.J., and Lindkaer Jensen, S.: Vagal, VIPergic control of pancreatic fluid and bicarbonate secretion; in Rehfeld and Amdrup, Gastrins and the vagus (Academic Press, New York, in press, 1979).
39. Fasth, S., Hulten, L., Johnson, B.J., and Zeitlin, I. J.: Changes in the kinin system in cat colon during atropine-resistant response to pelvic nerve stimulation. J. Physiol., Lond. 265: 56P-57P (1977).
40. Frandsen, E.K. and Moody, A.J.: Lipolytic action of a newly isolated vasoactive intestinal polypeptide. Horm. metab. Res. 5: 196-199 (1973).
41. Fronek, K. and Stahlgren, L.H.: Systemic and regional hemodynamic changes during food intake and digestion in nonanesthetized dogs. Circulation Res. 23: 687-692 (1968).
42. Fuxe, K., Hokfelt, T., Said, S.I., and Mutt, V.: Vasoactive intestinal polypeptide and the nervous system: immunohistochemical evidence for localization in central and peripheral neurons, particularly intracortical neurons of the cerebral cortex. Neurosci. Lett. 5: 241-246 (1977).
43. Gaginella, T.S., Mekhjian, H.S., and O’Dorisio, T.M.: Vasoactive intestinal peptide: quantification by radioimmunoassay in isolated cells, mucosa, and muscle of the hamster intestine. Gastroenterology 74: 718-721 (1978).
44. Gardner, J.D., Conlon, T.P., and Adams, T.D.: Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones. Gastroenterology 70: 29-35 (1976).
45. Giachetti, A., Said, S.I., Reynolds, R.C., and Königes, F.C.: Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc. natn. Acad. Sei. USA 74: 3424-3428 (1977).
46. Gray, E.G. and Whittaker, V.P.: The isolation of nerve endings from brain: an electron microscopic study of the cell fragments derived by homogenization and centrifugation. J. A nat., Lond. 96: 79-88 (1962).
47. Grossman, M.I.: Candidate hormones of the gut. Gastroenterology 67: 730-755 (1974).
48. Heding, L.G.: Radioimmunochemical determination of pancreatic and gut glucagon in plasma. Diabetologia 7: 10-19 (1971).
49. Hickson, J.C.D.: The secretion of pancreatic juice in response to stimulation of the vagus nerves in the pig. J. PhysioL, Lond. 206: 275-297 (1970).
50. Hillarp, N.-A.: Peripheral autonomic mechanisms; in Handbook of physiology, sect. 1, vol. 2, pp. 989-990 (Am. Physiol. Soc., Washington 1960).
51. Holst, J.J., Schaffalitzky de Muckadell, O.B., and Fahrenkrug, J.: Nervous control of pancreatic exocrine secretion in pigs. Acta physiol, scand. (in press, 1978).
52. Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., Morgan, B.A., and Morris, H.R.: Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, Lond. 258: 577-579 (1975).
53. Hulten, L.: Extrinsic nervous control of colonic motility and blood flow. Acta physiol, scand., suppl. 335, pp. 1-116 (1969).
54. Hunter, W.M. and Greenwood, F.C.: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature, Lond. 194: 495-496 (1962).
55. Kachelhoffer, J., Eloy, M.R., Pousse, A., Hohmatter, D., and Grenier, J.F.: Mesenteric vasomotor effects of vasoactive intestinal polypeptide: study on perfused isolated canine jejunal loops. Pflügers Arch. 352: 37-46 (1974).
56. Kerins, C. and Said, S.I.: Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide. Proc. Soc. exp. Biol. Med. 142: 1014-1017 (1973).
57. Kitamura, S., Yoshida, T., and Said, S.I.: Vasoactive intestinal polypeptide: inactivation in liver and potentiation in lung of anesthetized dogs. Proc. Soc. exp. Biol. Med. 148: 25-29 (1975).
58. Klaeveman, H.L., Conlon, T.P., Levy, A.G., and Gardner, J.D.: Effects of gastrointestinal hormones on adenylate cyclase activity in human jejunal mucosa. Gastroenterology 68: 667-675 (1975).
59. Konturek, S.J., Domschke, S., Domschke, W., Dembinski, A., Krol, R.f and Demling, L.: Cyclic AMP and bicarbonate responses of the dog pancreas to vasoactive intestinal peptide (VIP) and secretin. J. Lab. clin. Med. 88: 608-613 (1976).
60. Konturek, S.J., Domschke, S., Domschke, W., Wünsch, £., and Demling, L.: Comparison of pancreatic responses to portal and systemic secretin and VIP in cats. Am. J. Physiol. 232: E156-E158 (1977).
61. Konturek, S.J., Thor, P., Dembinski, A., and Krol, R.: Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Gastroenterology 68: 1527-1535 (1975).
62. Krejs, G.J., Barkley, R.M., Read, N.W., and Fordtran, J.S.: Intestinal secretion induced by vasoactive intestinal polypeptide. J. clin. Invest. 61: 1337-1345 (1978).
63. Laburthe, M., Besson, J., Hoa, D.H.B. et Rosselin, G.: Récepteurs du peptide intestinal vasoactif (VIP) dans les entérocytes: liaison spécifique et stimulation de TAMP cyclique. C. r. hebd. Séanc. Acad. Sci., Paris 284: 2139-2142 (1977).
64. Larsson, L.-I.: Ultrastructural localization of a new neuronal peptide (VIP). Histochemistry 54: 173-176 (1977).
65. Larsson, L.-I., Edvinsson, L., Fahrenkrug, J., Hâkanson, R., Owman, C., Schaffalitzky de Muckadell, O., and Sundler, F.: Immunohistochemical localization of a vasodilatory polypeptide (V IP) in cerebrovascular nerves. Brain Res. 113:400-404 (1976).
66. Larsson, L.-L; Fahrenkrug, J., Holst, J.J., and Schaffalitzky de Muckadell, O.B.: Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves. Life Sci. 22: 773-780 (1978).
67. Larsson, L.-I., Fahrenkrug, J., and Schaffalitzky de Muckadell, O.B.: Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. Science, N.Y. 197: 1374-1375 (1977).
68. Larsson, L.-I., Fahrenkrug, J., and Schaffalitzky de Muckadell, O.B.: Occurrence of nerves containing vasoactive intestinal polypeptide immunoreactivity in the male genital tract. Life Sci. 21: 503-508 (1977).
69. Larsson, L.-L; Fahrenkrug, J., Schaffalitzky de Muckadell, O., Sundler, F., Hakanson, R., and Rehfeld, J.F.: Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc. natn. Acad. Sci. USA 73: 3197-3200 (1976).
70. Lindkaer Jensen, S., Fahrenkrug, J., Holst, J.J., Vagn Nielsen, O., and Schaffalitzky de Muckadell, O.B.: Secretory effects of vasoactive intestinal polypeptide (VIP) on the isolated perfused porcine pancreas. Am. J. Physiol. 235: E387-E391 (1978).
71. Lindvall, M., Alumets, J., Edvinsson, L., Fahrenkrug, J., Hakanson, R., Hanko, J., Owman, C., Schaffalitzky de Muckadell, O.B., and Sundler, F.: Peptidergic (VIP) nerves in the mammalian choroid plexus. Neurosci. Lett. 9: 77-82 (1978).
72. Makhlouf, G.M. and Said, S.I.: The effect of vasoactive intestinal peptide (VIP) on digestive and hormonal function; in Thompson, Gastrointestinal hormones, pp. 599-610 (University of Texas Press, Austin 1975).
73. Morley, J.E., Garvin, T.J., Pekary, A.E., and Hershman, J.M.: Thyrotropin-releasing hormone in the gastrointestinal tract. Biochem. biophys. Res. Commun. 79: 314-318 (1977).
74. Muller, J.E., Strauss, E., and Yalow, R.S.: Cholecystokinin and its COOH-terminal octapeptide in the pig brain. Proc. natn. Acad. Sci. USA 74: 3035-3037 (1977).
75. Mutt, V.: Preparation of highly purified secretin. Ark. Kcmi 15: 69-74 (1959).
76. Mutt, V. and Said, S.I.: Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur. J. Biochem. 42: 581-589 (1974).
77. Nilsson, A.: Isolation, amino acid composition and terminal amino acid residues of the vasoactive octacosapeptide from chicken intestine. Partial purification of chicken secretin. FEBS Lett. 47: 284-289 (1974).
78. Nilsson, A.: Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequence. FEBS Lett. 60: 322-326 (1975).
79. Oliver, C., Eskay, R.L., Ben-Jonathan, N., and Porter, J.C.: Distribution and concentration of TRH in the rat brain. Endocrinology 95: 540-546 (1974).
80. Pearse, A.G.E., Polak, J.M., Adams, C., and Kendall, P.A., Diethylpyrocarbonate, a vapour-phase fixative for immunofluorescence studies on polypeptide hormones. Histochem. J. 6: 347-352 (1974).
81. Phillis, J.W.: The pharmacology of synapses, pp. 6-7 (Pergamon Press, Oxford 1966).
82. Phillis, J.W., Kirkpatrick, J.R., and Said, S.I.: Vasoactive intestinal polypeptide excitation of central neurons. Can. J. PhysioL Pharmacol. 56: 337-340 (1978).
83. Piper, P.J., Said, S.I., and Vane, J.R.: Effects on smooth muscle preparations of unidentified vasoactive peptides from intestine and lung. Nature, Lond. 225: 1144-1146 (1970).
84. Polak, J.M., Pearse, A.G.E., Garaud, J.-C., and Bloom, S.R.: Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract. Gut 15: 720-724 (1974).
85. Polak, J.M., Sullivan, S.N., Bloom, S.R., Facer, P., and Pearse, A.G.E.: Enkephalin-like immu noreactivity in the human gastrointestinal tract. Lancet i: 972-974 (1977).
86. Racusen, L.C. and Binder, H.J.: Alteration of large intestinal electrolyte transport by vasoactive intestinal polypeptide in the rat. Gastroenterology 73: 790-796 (1977).
87. Rattan, S., Said, S.I., and Goyal, R.K.: Effect of vasoactive intestinal polypeptide (VIP) on the lower esophageal sphincter pressure (LESP). Proc. Soc. exp. Biol. Med. 155: 40-43 (1977).
88. Read, J.B. and Burnstock, G.: Comparative histochemical studies of adrenergic nerves in the enteric plexuses of vertebrate large intestine. Comp. Biochem. Physiol. 27: 505-517 (1968).
89. Rehfeld, J.F.: Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J. biol. Chem. 253: 4022-4030 (1978).
90. Rehfeld, J.F.: Localisation of gastrins to neuro and adenohypophysis. Nature, Lond. 271: 771-773 (1978).
91. Renaud, L.P.: Peptides as neurotransmitters or neuromodulators; in Lipton, Di Prascio and Kiliane, Psychopharmacology, a generation of progress, p. 423 (Raven Press, New York 1978).
92. Rodbard, D., Ruder, H.J., Vaitukaitis, J., and Jacobs, H.S.: Mathematical analysis of kinetics of radioligand assays: improved sensitivity obtained by delayed addition of labeled ligand. J. din. Endocr. Metab. 33: 343-355 (1971).
93. Ryan, J. and Cohen, S.: Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure. Gastroenterology 73: 870-872 (1977).
94. Said, S.I. and Faloona, G.R.: Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. New Engl. J. Med. 293: 155-160 (1975).
95. Said, S.I. and Mutt, V.: Polypeptide with broad biological activity: isolation from small intestine. Science, N.Y. 169: 1217-1218 (1970).
96. Said, S.I. and Mutt, V.: Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature, Lond. 225: 863-864 (1970).
97. Said, S.I. and Mutt, V.: Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur. J. Biochem.28: 199-204 (1972).
98. Said, S.I. and Rosenberg, R.N.: Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science, N.Y. 192: 907-908 (1976).
99. Schaffalitzky de Muckadell, O.B., Fahrenkrug, J., Holst, J.J., and Lauritsen, K.B.: Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli. Scand. J. Gastroent. 12: 793-799 (1977).
100. Schebalin, M., Said, S.I., and Makhlouf, G.M.: Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide. Am. J. Physiol. 232: E197-E200 (1977).
101. Schwartz, C.J., Kimberg, D.V., Sheerin, H.E., Field M., and Said, S.I.: Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J. din. Invest. 54: 536-544 (1974).
102. Simon, B. and Kather, H.: Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide. Gastroenterology 74: 722-725 (1978).
103. Solcia, E., Polak, J.M., Pearse, A.G.E., Forss-mann, W.G., Larsson, L.-I., Sundler, F., Lechago, J., Grimelius, L., Fujita, T., Creutzfeldt, W., Gepts, W., Falkmer, S., Lefranc, G., Heitz, P., Hage, E., Buchan, A.M.J., Bloom, S.R., and Grossman, M.I.: Lausanne 1977 classification of gastroenteropancreatic endocrine cells; in Bloom, Gut hormones, pp. 40-48 (Churchill/Livingstone, London/Edinburgh 1978).
104. Strunz, U.T., Walsh, J.H., Bloom, S.R., Thompson, M.R., and Grossman, M.I.: Lack of hepatic inactivation of canine vasoactive intestinal peptide. Gastroenterology 73: 768-771 (1977).
105. Studer, R.O., Trzeciak, A. und Lergier, W.: Isolierung und Aminosäuresequenz von Substanz P aus Pferdedarm. Helv. chim. Acta 56: 860-866 (1973).
106. Sundler, F., Alumets, J., Hâkanson, R., Fahrenkrug, J., and Schaffalitzky de Muckadell, O.: Peptidergic (VIP) nerves in the pancreas. Histochemistry 55: 173-176 (1978).
107. Sundler, F., Alumets, J., Håkanson, R., Ingemansson, S., Fahrenkrug, J., and Schaffalitzky de Muckadell, O.: VIP innervation of the gallbladder. Gastroenterology 72: 1375-1377 (1977).
108. Thorell, J.I. and Johansson, B.G.: Enzymatic iodination of polypeptides with125I to high specific activity. Biochim. biophys. Acta 251: 363-369 (1971).
109. Thulin, L.: Effect of gastrointestinal polypeptides on hepatic bile flow and splanchnic circulation. Acta chir. scand., suppl. 441, pp. 5-31 (1973).
110. Thulin, L. and Olsson, P.: Effects of intestinal peptide mixture G2 and vasoactive intestinal peptide VIP on splanchnic circulation in the dog. Acta chir. scand. 139: 691-697 (1973).
111. Uvnäs-Wallensten, K.: Vagal release of antral hormones; in Bloom, Gut hormones, pp. 389-393 (Churchill/Livingstone, London/Edinburgh 1978).
112. Vagne, M. and Troitskaja, V.: Effect of secretin, glucagon and VIP on gallbladder contraction. Digestion 14: 62-67 (1976).
113. Valenzuela, J.E.: Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 71: 1019-1022 (1976).
114. Waldman, D.B., Gardner, J.D., Zfass, A.M., and Makhlouf, G.M.: Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity. Gastroenterology 73: 518-523 (1977).
115. Whittaker, V.P.: The application of subcellular fractionation techniques to the study of brain function. Prog. Biophys. molec. Biol. 15: 39-96 (1965).
116. Yalow, R.S. and Berson, S.A.: Immunoassay of endogenous plasma insulin in man. J. clin. Invest. 39: 1157-1175 (1960).
117. Yanaihara, N., Sakagami, M., Sato, H., Yamamoto, K., Hashimoto, T., Yanaihara, C., Ito, Z., Yamaguchi, K., and Abe, K.: Immunological aspects of secretin, substance P, and VIP. Gastroenterology 72: 803-810 (1977).